Targeting epigenetic mechanisms as an emerging therapeutic strategy in pulmonary hypertension disease
{{output}}
Pulmonary arterial hypertension (PAH) is a multifactorial cardiopulmonary disease characterized by an elevation of pulmonary artery pressure (PAP) and pulmonary vascular resistance (PVR), which can lead to right ventricular (RV) failure, multi-organ dysfunctio... ...
